These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 10515150)

  • 1. Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.
    Bell KD; Ramilo O; Vitetta ES
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1411-5. PubMed ID: 8434001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.
    Fang H; Pincus SH
    J Virol; 1995 Jan; 69(1):75-81. PubMed ID: 7983770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of an immunotoxin reactive with a shared B and T cell activation antigen.
    Harris P; Reed E; Suciu-Foca N
    Transplant Proc; 1991 Feb; 23(1 Pt 1):309-10. PubMed ID: 1990539
    [No Abstract]   [Full Text] [Related]  

  • 4. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
    Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
    Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
    Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
    J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution to the regulation of virus replication in cells latently infected with human immunodeficiency virus 1.
    Owatari S; Zhang J; Gao M; Tanabe-Tochikura A; Wakamiya N; Tsuchie H; Kurimura T
    Acta Virol; 1997 Feb; 41(1):21-6. PubMed ID: 9199710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines.
    Stanley SK; Bressler PB; Poli G; Fauci AS
    J Immunol; 1990 Aug; 145(4):1120-6. PubMed ID: 1696294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip.
    Henderson EE; Tsygankov AY; Merlo JJ; Romano G; Guan M
    Virology; 1999 Nov; 264(1):125-33. PubMed ID: 10544137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL; Li JL; Vitetta ES
    J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
    Derdeyn CA; Kilby JM; Miralles GD; Li LF; Sfakianos G; Saag MS; Hockett RD; Bucy RP
    J Infect Dis; 1999 Dec; 180(6):1851-62. PubMed ID: 10558941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
    Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
    Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of latent human immunodeficiency virus 1 by human herpesvirus 6 infection.
    Isegawa Y; Katahira J; Yamanishi K; Sugimoto N
    Acta Virol; 2007; 51(1):13-20. PubMed ID: 17432939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.
    Jiménez JL; González-Nicolás J; Alvarez S; Fresno M; Muñoz-Fernández MA
    J Virol; 2001 May; 75(10):4655-63. PubMed ID: 11312336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
    Siena S; Bregni M; Formosa A; Brando B; Lappi DA; Bonadonna G; Gianni AM
    J Biol Regul Homeost Agents; 1989; 3(2):84-8. PubMed ID: 2479229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How HIV hijacks host cells.
    Dorrell S
    Mol Med Today; 2000 Apr; 6(4):140. PubMed ID: 10740251
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal attraction in vitro and in vivo.
    Youle RJ
    J Natl Cancer Inst; 1988 May; 80(6):388-9. PubMed ID: 3259264
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1.
    Klug G; Cole FM; Hicar MD; Watt C; Peters T; Pincus SH
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous activation of human immunodeficiency virus type 1 in an immunotoxin-resistant variant T cell line.
    Fang H; Pincus S
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1345-9. PubMed ID: 10515150
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.